Buys
Open market- Shares
- +5,675
- Avg price
- $1.94
- Total value
- +$10,981
Thomas R. Staab II - Chief Financial Officer at TENAX THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- TENX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Thomas R. Staab II in TENAX THERAPEUTICS, INC.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +5,675
- Share %
- 100%
- Total value
- +$10,981
Reported holdings for Thomas R. Staab II in TENAX THERAPEUTICS, INC.
Form 4 holding
Chief Financial Officer
TENAX THERAPEUTICS, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 450,000
- Estimated value
- $954,000
- Report date
- 11 Sep 2026
- Price
- $2.12
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 450,000
Form 4 holding
Chief Financial Officer
TENAX THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 15,675
- Estimated value
- $30,331
- Report date
- 11 Sep 2026
- Price
- $1.94
- Ownership
- Direct
Transaction history for Thomas R. Staab II in TENAX THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.